New Entrants in the Weight Loss Drugs Market

Weight loss drugs have gained significant prominence over the past few years. The weight loss drugs market is driven by the rising prevalence of obesity worldwide and the increasing awareness of associated health risks such as diabetes, cardiovascular diseases, and certain cancers. Novo Nordisk and Eli Lilly, the first movers in the market, have seen their share prices skyrocket and may be the first pharmaceutical companies to reach a market capitalization of USD1 trillion. Several pharmaceutical companies and biotech companies are trying to enter the market. These new entrants are trying to develop competitive drugs in forms supporting better efficacy, treatment of other related diseases, less frequent dosage with longer-lasting effects or oral administration method.